sumatriptan succinate · Azurity · NDA 206099
Onzetra Xsail
Earliest generic entry, as listed
20 Oct 2034
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 10076614.
Listed patents · 11 unexpired
17 Orange Book listing rows for 11 patents. FDA lists a patent once for each use code, and lists its pediatric extension as a separate row.
| Patent | Claims | Expires |
|---|---|---|
| US 10076614 | drug product · sets the listed date | 20 Oct 2034 |
| US 10478574 | use U-2404 | 4 Nov 2033 |
| US 8978647 | drug product | 6 Dec 2030 |
| US 9649456 | drug product, use U-1719, U-2010, U-2011 | 21 Oct 2030 |
| US 9649456 listing row | drug product, use U-1719 | 21 Oct 2030 |
| US 9649456 listing row | drug product, use U-2010 | 21 Oct 2030 |
| US 9649456 listing row | drug product, use U-2011 | 21 Oct 2030 |
| US 8899229 | drug product | 18 Aug 2030 |
| US 8550073 | drug product | 22 Oct 2029 |
| US 10076615 | use U-2010, U-2011, U-2404 | 30 Jul 2029 |
| US 10076615 listing row | use U-2010 | 30 Jul 2029 |
| US 10076615 listing row | use U-2011 | 30 Jul 2029 |
| US 10076615 listing row | use U-2404 | 30 Jul 2029 |
| US 10722667 | drug product | 30 Dec 2028 |
| US 8875704 | drug product, use U-1809 | 7 Apr 2028 |
| US 10398859 | drug product | 19 Dec 2027 |
| US 10124132 | drug product, use U-1719, U-2010, U-2011 | 6 Mar 2027 |
| US 10124132 listing row | drug product, use U-1719 | 6 Mar 2027 |
| US 10124132 listing row | drug product, use U-2010 | 6 Mar 2027 |
| US 10124132 listing row | drug product, use U-2011 | 6 Mar 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 206099 · 001 · RLD · discontinued | powder, nasal | EQ 11MG BASE | 20 Oct 2034 |
Expired or delisted (1)
- US 11571531 · use U-1809 · 23 Feb 2026